PHARMA NORD EXPORT ApS — Credit Rating and Financial Key Figures
CVR number: 70996510
Sadelmagervej 30-32, 7100 Vejle
webmaster@pharmanord.dk
tel: 75857474
Income statement (kDKK)
2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Fiscal period length | 12 | 12 | 12 | 12 | 12 |
| Net sales | |||||
| Gross profit | 25 070.00 | 26 012.00 | 26 460.00 | 32 656.03 | 35 054.06 |
| Employee benefit expenses | -22 155.65 | -23 048.18 | |||
| Other operating expenses | -24.89 | ||||
| Total depreciation | -1 253.05 | -1 484.73 | |||
| EBIT | 3 825.00 | 3 416.00 | 4 566.00 | 9 222.44 | 10 521.14 |
| Other financial income | 655.19 | 532.43 | |||
| Other financial expenses | -1 030.41 | -1 093.61 | |||
| Pre-tax profit | 2 704.00 | 3 188.00 | 2 130.00 | 8 847.22 | 10 021.61 |
| Income taxes | -2 496.33 | -3 078.91 | |||
| Net earnings | 2 704.00 | 3 188.00 | 2 130.00 | 6 350.89 | 6 942.70 |
Assets (kDKK)
2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Intangible assets total | |||||
| Land and waters | 34 850.07 | 43 357.46 | |||
| Machinery and equipment | 2 627.03 | 3 242.87 | |||
| Tangible assets total | 37 477.11 | 46 600.33 | |||
| Investments total | 118 406.00 | 116 326.00 | 102 453.00 | ||
| Long term receivables total | |||||
| Finished products/goods | 12 826.28 | 17 839.52 | |||
| Inventories total | 12 826.28 | 17 839.52 | |||
| Current trade debtors | 13 813.25 | 15 689.19 | |||
| Current amounts owed by group member comp. | 9 443.75 | 12 578.65 | |||
| Prepayments and accrued income | 492.83 | 443.36 | |||
| Current other receivables | 962.30 | 9 367.53 | |||
| Short term receivables total | 24 712.13 | 38 078.74 | |||
| Cash and bank deposits | 11 358.24 | 6 443.49 | |||
| Cash and cash equivalents | 11 358.24 | 6 443.49 | |||
| Balance sheet total (assets) | 118 406.00 | 116 326.00 | 102 453.00 | 86 373.77 | 108 962.08 |
Equity and liabilities (kDKK)
2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Share capital | 40 823.00 | 44 001.00 | 46 117.00 | 200.00 | 200.00 |
| Asset revaluation reserve | 7 419.23 | 7 341.02 | |||
| Shares repurchased | 15 000.00 | ||||
| Retained earnings | -2 704.00 | -3 188.00 | -2 130.00 | 23 413.64 | 14 694.69 |
| Profit of the financial year | 2 704.00 | 3 188.00 | 2 130.00 | 6 350.89 | 6 942.70 |
| Minority interest (BS) | 103.09 | 125.29 | |||
| Shareholders equity total | 40 823.00 | 44 001.00 | 46 117.00 | 37 486.85 | 44 303.71 |
| Provisions | 7 087.12 | 7 126.29 | |||
| Non-current loans from credit institutions | 10 023.80 | 9 467.76 | |||
| Non-current liabilities total | 10 023.80 | 9 467.76 | |||
| Current loans from credit institutions | 607.35 | 556.03 | |||
| Current trade creditors | 2 617.24 | 3 445.81 | |||
| Current owed to participating | 5 250.00 | 5 481.44 | |||
| Short-term deferred tax liabilities | 1 257.01 | 1 478.73 | |||
| Other non-interest bearing current liabilities | 22 044.41 | 37 102.30 | |||
| Current liabilities total | 31 776.01 | 48 064.32 | |||
| Balance sheet total (liabilities) | 40 823.00 | 44 001.00 | 46 117.00 | 86 373.77 | 108 962.08 |
Try the full version of our system for free
- Professional credit risk reports
- Create your own estimates for any company
- Valuation analysis
- All 400,000+ Danish companies
- See instructions
... and more!
No registration needed.